Clinical Trial Update: Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring curcumin and yoga therapy for individuals at risk of Alzheimer's disease with mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Mild Cognitive Impairment | Phase 2 | Status: UNKNOWN